Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT06059547 |
Title | Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | CatalYm GmbH |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
IRCCS Ospedale San Raffaele Hospital Vita-Salute San Raffaele University | Milano | 20132 | Italy | Details | ||
Fondazione IRCCS Istituto Nazionale dei Tumori | Milano | 20133 | Italy | Details | ||
Istituto Nazionale Tumori IRCCS - Fondazione Pascale | Napoli | 80131 | Italy | Details | ||
Istituto Oncologico Veneto, IOV - IRCCS | Padova | 35128 | Italy | Details | ||
ASL Salerno, Ospedale Andrea Tortora | Pagani | 84016 | Italy | Details | ||
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, UOC Oncologia Medica | Roma | 00168 | Italy | Details | ||
A.O.U. Città della Salute e della Scienza di Torino | Torino | 10126 | Italy | Details | ||
Azienda Ospedaliera Ordine Mauriziano di Torino Ospedale Umberto I , SCDU Oncologia | Torino | 10128 | Italy | Details |